Article By:
BioMedReports
Friday, November 21, 2014 3:18 AM EDT
AEZS announced the opening of a new clinical site at the Hollings Cancer Center of the Medical University of South Carolina. MRNA announced they have amended their license agreement regarding the development and commercialization of microRNA-based therapeutics.